Medifast MED Accounts payable and other current liabilities
Accounts payable and other current liabilities at other companies
Other financials
Where this comes from
Reported directly by Medifast in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medifast's accounts payable and other current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medifast's accounts payable and other current liabilities?
- Medifast (MED) reported accounts payable and other current liabilities of -$1.45M in Q1 2026.
- How has Medifast's accounts payable and other current liabilities changed year-over-year?
- Medifast's accounts payable and other current liabilities increased by 75.8% year-over-year, from -$6M to -$1.45M.
- What is the long-term trend for Medifast's accounts payable and other current liabilities?
- Over 4 years (2021 to 2025), Medifast's accounts payable and other current liabilities has grown at a -18.6% compound annual growth rate (CAGR), from $54.38M to -$23.91M.